Offstream
news

Algeria begins producing the CoronaVac COVID-19 vaccine developed by Sinovac, with expected production of eight million doses per month.
2021-09-29

The National Medical Products Administration approves China's first mixed-COVID-19 vaccine trial combining the CoronaVac vaccine made by Sinovac and the DNA-based vaccine made by Inovio.
2021-08-11

The Chilean government announces that they will begin administering booster doses for those who have received the Sinovac CoronaVac vaccine beginning on August 11 for people over the age of 55 using the Oxford-AstraZeneca vaccine and in September for people under the age of 55 using the Pfizer-BioNTech vaccine in order to protect the population from the Delta variant.
2021-08-5

The Drug Regulatory Authority grants Emergency Use Authorization for Sinovac CoronaVac vaccine.
2021-04-9

Mauritania begins a vaccination campaign against COVID-19 after receiving 500,000 doses of the Sinovac CoronaVac vaccine from China.
2021-03-26

Malaysia grants conditional approval for the use of the Oxford-AstraZeneca and Sinovac CoronaVac vaccines.
2021-03-2

Thailand begins a vaccination campaign against COVID-19 using the Sinovac CoronaVac vaccine. Government ministers and health workers are among the first to receive doses of the vaccine.
2021-02-28

Hong Kong begins administering vaccines to the general public with the Sinovac CoronaVac vaccine.
2021-02-26

Hong Kong receives one million doses of the Sinovac CoronaVac vaccine, a day after it was approved for emergency use in the city.
2021-02-19

Indonesia aims to start administering COVID-19 vaccines early next month, according to the Coordinating Ministry for Maritime and Investment Affairs. Sinopharm and G42 Healthcare will supply five million doses starting next month, CanSino Biologics will supply 100,000 doses that same time, and Sinovac will supply three million doses of CoronaVac by December. All three vaccines are currently in Phase III trials in various countries.
2020-10-12